{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:56Z","timestamp":1793640716537,"version":"4.5.1"},"reference-count":35,"publisher":null,"issue":"8","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim.<\/jats:italic>\n                    To study metabolic molecules (adiponectin, adipsin, resistin, glucagon-like peptide-1 (GLP-1), glucagon, secretin) of adipose tissue in atherosclerotic plaques (AP) and their associations with AP instability in men with coronary atherosclerosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Material and methods.<\/jats:italic>\n                    Metabolic molecules (adipocytokines and metabolic hormones) of adipose tissue can act as enzymes, hormones or growth factors in modulating insulin resistance and lipid and glucose metabolism and indirectly influence the course of the atherosclerotic process. This study included 48 men from whom 139 coronary artery (CA) samples were collected during coronary artery bypass grafting, after obtaining the informed consent. According to the histological conclusion, 84 (60.4%) CA plaques were stable, 44 (31.7%) were unstable, and 11 histological samples had a conditionally unchanged CA intima (7.9%). The concentrations of adiponectin, adipsin, resistin, GLP-1, glucagon, and secretin were measured in AP homogenates by multiplex analysis using the Human Metabolic Hormone V3 panel (MILLIPLEX, Germany). During the study, demographic and anthropometric characteristics, medical history, and presence of chronic diseases were recorded.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results.<\/jats:italic>\n                    The glucagon concentration in the conditionally unchanged intima was 16.7% lower and in the fragments of unstable atherosclerotic plaques 41.2% lower than in fragments of stable APs. However, the glucagon concentration in stable APs was 28% higher than in unstable APs. The secretin concentration in the conditionally unchanged intima was also lower than in stable APs by 41.2%, while in stable APs, the secretin concentration was 20% higher than in unstable APs.\n                    <jats:italic\/>\n                    The adiponectin concentrations were directly correlated with serum high-density lipoprotein cholesterol (HDL-C) concentrations (r=0.286; p=0.002), while the secretin concentrations were inversely correlated with serum HDL-C concentrations (r= \u20130.199; p=0.038). The probability of having an unstable AP (in relation to conditionally unchanged intima) increases by 35.8% with an increase in the AP glucagon concentration by 1 pg\/mg protein. The probability of having a stable AP (in relation to unchanged intima) increases by 29.4% with an increase in the AP glucagon concentration by 1 pg\/mg protein and by 10.1% with an increase in the AP secretin concentration by 1 pg\/mg protein.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion.<\/jats:italic>\n                    The AP adiponectin concentration directly correlates and the AP secretin concentration inversely correlates with the serum concentration of HDL-C. The presence of both stable and unstable APs is directly associated with the AP glucagon concentration in men with coronary atherosclerosis. The AP secretin concentration is directly associated with plaque stability in men with coronary atherosclerosis. Further thorough study of the identified markers in atherosclerotic lesions will allow using them as potential targets for therapy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>\u00a0<\/jats:italic>\n                  <\/jats:p>\n                  <jats:p>\u00a0<\/jats:p>","DOI":"10.18087\/cardio.2024.8.n2634","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:52:45Z","timestamp":1726127565000},"page":"39-47","source":"Crossref","is-referenced-by-count":4,"title":["Biomolecules of Adipose Tissue in Atherosclerotic Plaques of Men With Coronary Atherosclerosis"],"prefix":"10.68900","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5316-4664","authenticated-orcid":true,"given":"E. V.","family":"Garbuzova","sequence":"first","affiliation":[{"name":"Research Institute of Internal and Preventive Medicine, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3538-0280","authenticated-orcid":true,"given":"Ya. V.","family":"Polonskaya","sequence":"additional","affiliation":[{"name":"Research Institute of Internal and Preventive Medicine, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2268-4186","authenticated-orcid":true,"given":"E. V.","family":"Kashtanova","sequence":"additional","affiliation":[{"name":"Research Institute of Internal and Preventive Medicine, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-6540","authenticated-orcid":true,"given":"E. M.","family":"Stakhneva","sequence":"additional","affiliation":[{"name":"Research Institute of Internal and Preventive Medicine, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0436-2549","authenticated-orcid":true,"given":"V. S.","family":"Shramko","sequence":"additional","affiliation":[{"name":"Research Institute of Internal and Preventive Medicine, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-1258","authenticated-orcid":true,"given":"I. S.","family":"Murashov","sequence":"additional","affiliation":[{"name":"Meshalkin National Medical Research Center, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1345-2199","authenticated-orcid":true,"given":"A. V.","family":"Kurguzov","sequence":"additional","affiliation":[{"name":"Meshalkin National Medical Research Center, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9818-8678","authenticated-orcid":true,"given":"A. M.","family":"Chernyavsky","sequence":"additional","affiliation":[{"name":"Meshalkin National Medical Research Center, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4936-8362","authenticated-orcid":true,"given":"Yu. I.","family":"Ragino","sequence":"additional","affiliation":[{"name":"Research Institute of Internal and Preventive Medicine, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Costa RM, Neves KB, Tostes RC, Lobato NS. Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity. Frontiers in Physiology. 2018;9:253. DOI: 10.3389\/fphys.2018.00253","DOI":"10.3389\/fphys.2018.00253"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kim O.T., Dadaeva V.A., Korolev A.I., Drapkina O.M. Perivascular adipose tissue in the pathogenesis of cardiovascular disease. Russian Journal of Cardiology. 2021;26(11):128\u201335. DOI: 10.15829\/1560-4071-2021-4567","DOI":"10.15829\/1560-4071-2021-4567"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ryabova E.A., Ragino Yu.I. Proinflammatory adipokines and cytokines in abdominal obesity as a factor in the development of atherosclerosis and renal pathology. Ateroscleroz. 2021;17(4):101\u201310. DOI: 10.52727\/2078-256X-2021-17-4-101-110","DOI":"10.52727\/2078-256X-2021-17-4-101-110"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sahin-Efe A, Katsikeris F, Mantzoros CS. Advances in adipokines. Metabolism. 2012;61(12):1659\u201365. DOI: 10.1016\/j.metabol.2012.09.001","DOI":"10.1016\/j.metabol.2012.09.001"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chang L, Milton H, Eitzman DT, Chen YE. Paradoxical Roles of Perivascular Adipose Tissue in Atherosclerosis and Hypertension. Circulation Journal. 2013;77(1):11\u20138. DOI: 10.1253\/circj.CJ-12-1393","DOI":"10.1253\/circj.CJ-12-1393"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Yoo HJ, Choi KM. Adipokines as a novel link between obesity and atherosclerosis. World Journal of Diabetes. 2014;5(3):357\u201363. DOI: 10.4239\/wjd.v5.i3.357","DOI":"10.4239\/wjd.v5.i3.357"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. Journal of the American Society of Hypertension. 2013;7(1):85\u201394. DOI: 10.1016\/j.jash.2012.11.008","DOI":"10.1016\/j.jash.2012.11.008"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Van de Voorde J, Pauwels B, Boydens C, Decaluw\u00e9 K. Adipocytokines in relation to cardiovascular disease. Metabolism. 2013;62(11):1513\u201321. DOI: 10.1016\/j.metabol.2013.06.004","DOI":"10.1016\/j.metabol.2013.06.004"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Anfossi G, Russo I, Doronzo G, Pomero A, Trovati M. Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells. Mediators of Inflammation. 2010;2010:174341. DOI: 10.1155\/2010\/174341","DOI":"10.1155\/2010\/174341"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"De La Cuesta F, Alvarez-Llamas G, Maroto AS, Donado A, Zubiri I, Posada M et al. A Proteomic Focus on the Alterations Occurring at the Human Atherosclerotic Coronary Intima. Molecular & Cellular Proteomics. 2011;10(4):M110.003517. DOI: 10.1074\/mcp.M110.003517","DOI":"10.1074\/mcp.M110.003517"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"You S-A, Archacki SR, Angheloiu G, Moravec CS, Rao S, Kinter M et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiological Genomics. 2003;13(1):25\u201330. DOI: 10.1152\/physiolgenomics.00124.2002","DOI":"10.1152\/physiolgenomics.00124.2002"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bagnato C, Thumar J, Mayya V, Hwang S-I, Zebroski H, Claffey KP et al. Proteomics Analysis of Human Coronary Atherosclerotic Plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Molecular & Cellular Proteomics. 2007;6(6):1088\u2013102. DOI: 10.1074\/mcp.M600259-MCP200","DOI":"10.1074\/mcp.M600259-MCP200"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"De La Cuesta F, Alvarez-Llamas G, Maroto AS, Donado A, Juarez-Tosina R, Rodriguez-Padial L et al. An optimum method designed for 2-D DIGE analysis of human arterial intima and media layers isolated by laser microdissection. Proteomics Clinical Applications. 2009;3(10):1174\u201384. DOI: 10.1002\/prca.200900053","DOI":"10.1002\/prca.200900053"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Auguet T, Aragon\u00e8s G, Guiu-Jurado E, Berlanga A, Curriu M, Martinez S et al. Adipo\/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque. BMC cardiovascular disorders. 2016;16(1):149. DOI: 10.1186\/s12872-016-0320-5","DOI":"10.1186\/s12872-016-0320-5"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F et al. Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque. Clinical and Experimental Immunology. 2006;143(3):452\u20137. DOI: 10.1111\/j.1365-2249.2006.03025.x","DOI":"10.1111\/j.1365-2249.2006.03025.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Karaduman M, Sengul A, Oktenli C, Pekel A, Yesilova Z, Musabak U et al. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clinical Endocrinology. 2006;64(2):196\u2013202. DOI: 10.1111\/j.1365-2265.2006.02448.x","DOI":"10.1111\/j.1365-2265.2006.02448.x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Yanofsky R, Sancho C, Gasbarrino K, Zheng H, Doonan RJ, Jaunet F et al. Expression of Resistin, Chemerin, and Chemerin\u2019s Receptor in the Unstable Carotid Atherosclerotic Plaque. Stroke. 2021;52(8):2537\u201346. DOI: 10.1161\/STROKEAHA.120.030228","DOI":"10.1161\/STROKEAHA.120.030228"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Lu L, Zhang RY, Wang XQ, Liu ZH, Shen Y, Ding FH et al. C1q\/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. European Heart Journal. 2016;37(22):1762\u201371. DOI: 10.1093\/eurheartj\/ehv649","DOI":"10.1093\/eurheartj\/ehv649"},{"key":"ref19","unstructured":"Waksman R, Serruys PW, Schaar J. The vulnerable plaque. 2 nd ed. -Abingdon: Informa healthcare;2007. - 512 p. ISBN 978-1-84184-621-7"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021;42(34):3227\u2013337. DOI: 10.1093\/eurheartj\/ehab484","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science. 2002;103(2):137\u201342. DOI: 10.1042\/cs1030137","DOI":"10.1042\/cs1030137"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Matsubara M, Maruoka S, Katayose S. Decreased Plasma Adiponectin Concentrations in Women with Dyslipidemia. The Journal of Clinical Endocrinology & Metabolism. 2002;87(6):2764\u20139. DOI: 10.1210\/jcem.87.6.8550","DOI":"10.1210\/jcem.87.6.8550"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Park S-H, Kim JY, Lee JH, Park H-Y. Association between plasma adiponectin and high-density lipoprotein cholesterol in postmenopausal women. Clinical Biochemistry. 2010;43(13\u201314):1069\u201373. DOI: 10.1016\/j.clinbiochem.2010.06.002","DOI":"10.1016\/j.clinbiochem.2010.06.002"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"M\u00fcller TD, Finan B, Clemmensen C, DiMarchi RD, Tsch\u00f6p MH. The New Biology and Pharmacology of Glucagon. Physiological Reviews. 2017;97(2):721\u201366. DOI: 10.1152\/physrev.00025.2016","DOI":"10.1152\/physrev.00025.2016"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ceriello A, Genovese S, Mannucci E, Gronda E. Glucagon and heart in type 2 diabetes: new perspectives. Cardiovascular Diabetology. 2016;15(1):123. DOI: 10.1186\/s12933-016-0440-3","DOI":"10.1186\/s12933-016-0440-3"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbj\u00f6rnsd\u00f3ttir S et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52(1):65\u201373. DOI: 10.1007\/s00125-008-1190-x","DOI":"10.1007\/s00125-008-1190-x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus \u2013 Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133(24):2459\u2013502. DOI: 10.1161\/CIRCULATIONAHA.116.022194","DOI":"10.1161\/CIRCULATIONAHA.116.022194"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Marx N, Husain M, Lehrke M, Verma S, Sattar N. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation. 2022;146(24):1882\u201394. DOI: 10.1161\/CIRCULATIONAHA.122.059595","DOI":"10.1161\/CIRCULATIONAHA.122.059595"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Osaka N, Kushima H, Mori Y, Saito T, Hiromura M, Terasaki M et al. Anti-inflammatory and atheroprotective properties of glucagon. Diabetes and Vascular Disease Research. 2020;17(5):1479164120965183. DOI: 10.1177\/1479164120965183","DOI":"10.1177\/1479164120965183"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Chow BKC. Molecular Cloning and Functional Characterization of a Human Secretin Receptor. Biochemical and Biophysical Research Communications. 1995;212(1):204\u201311. DOI: 10.1006\/bbrc.1995.1957","DOI":"10.1006\/bbrc.1995.1957"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Glaser S, Lam IP, Franchitto A, Gaudio E, Onori P, Chow BK et al. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology. 2010;52(1):204\u201314. DOI: 10.1002\/hep.23657","DOI":"10.1002\/hep.23657"},{"key":"ref32","unstructured":"Afroze S, Meng F, Jensen K, McDaniel K, Rahal K, Onori P et al. The physiological roles of secretin and its receptor. Annals of Translational Medicine. 2013;1(3):29. DOI: 10.3978\/j.issn.2305-5839.2012.12.01"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"K\u00f6rner M, Miller LJ. Alternative Splicing of Pre-mRNA in Cancer: focus on G protein-coupled peptide hormone receptors. The American Journal of Pathology. 2009;175(2):461\u201372. DOI: 10.2353\/ajpath.2009.081135","DOI":"10.2353\/ajpath.2009.081135"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Campbell G. Cotransmission. Annual Review of Pharmacology and Toxicology. 1987;27(1):51\u201370. DOI: 10.1146\/annurev.pa.27.040187.000411","DOI":"10.1146\/annurev.pharmtox.27.1.51"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Laurila S, Rebelos E, Lahesmaa M, Sun L, Schnabl K, Peltomaa T-M et al. Novel effects of the gastrointestinal hormone secretin on cardiac metabolism and renal function. American Journal of Physiology-Endocrinology and Metabolism. 2022;322(1):E54\u201362. DOI: 10.1152\/ajpendo.00260.2021","DOI":"10.1152\/ajpendo.00260.2021"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/2634\/1715","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:40Z","timestamp":1793639800000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/2634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,31]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2024.8.n2634","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,31]]}}}